Landos Biopharma (LABP) PT Lowered to $7 at JPMorgan
Tweet
Share
E-mailGet Alerts LABP Hot Sheet
Price: $22.93 --0%
Rating Summary:
1 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 2 | New: 1
Rating Summary:
1 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 2 | New: 1
Join SI Premium – FREE
JPMorgan analyst Jessica Fye lowered the price target on Landos Biopharma (NASDAQ: LABP) to $7.00 (from $15.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Citi Upgrades Domino's Pizza Enterprises Ltd. (DMP:AU) (DPZUF) to Buy
- Marvell (MRVL) PT Raised to $280 at Wolfe Research
- SMG Swiss Marketplace (SMG:SW) PT Raised to CHF38 at Berenberg
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
